Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
396
NCT01501617
Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia
Phase: Phase 1/2
Role: Lead Sponsor
Start: Dec 31, 2011
Completion: Dec 31, 2012
NCT02960204
Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension
Phase: Phase 2
Start: Oct 17, 2016
Completion: Apr 8, 2019
NCT03662854
Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss
Phase: Phase 1
Start: Jul 2, 2018
Completion: Jan 21, 2021
NCT04435847
Safety and Efficacy of HST 001 in Male Pattern Hair Loss
Start: May 26, 2020
Completion: Jan 20, 2021
NCT04803227
Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19
Start: Mar 11, 2021
Completion: May 28, 2021
NCT05082831
Human ECM Implanted Within Microfracture Interstices & the Cartilage Defect in the Knee to Regenerate Hyaline Cartilage
Start: Nov 15, 2021
Completion: Jan 16, 2023